Companies / Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc.

OTC: SGMOCIK 1001233RICHMOND, CA

Financials · FY2025

Revenue$39.55M
Net income$-122.93M
Total debt—
Cash$27.59M
Diluted EPS$-0.44
Shares outstanding414.3M

Ownership

414.3M shares outstanding · as of May 11, 2026
0.94%Insiders
Ownership
Insiders0.94%3,880,134
10%+ / strategic9.75%40,400,067
Institutions16.27%67,413,309
Public float73.04%302,595,337

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Macrae SandyCEOPRESIDENT, CEO AND DIRECTOR · Director
0.46%1,895,043
Duraibabu PrathyushaPRINCIPAL FINANCIAL OFFICER
0.16%660,042
Willoughby Scott B.SVP, CHIEF LEGAL OFFICER, SECY
0.16%647,370
Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER
0.08%328,733
Jain NikunjPrincipal Accounting Officer
0.06%235,292
Davis Gregory DHead of Research & Technology
0.03%113,654

Institutional holders 110

View all →
HolderValue% of shares
Vanguard Group Inc$5.04M2.90%
BlackRock, Inc.$1.92M1.10%
Two Sigma Advisers, LP$1.82M1.05%
Two Sigma Investments, LP$1.55M1.51%
Balyasny Asset Management L.P.$1.31M1.28%
Jane Street Group, LLC$1.23M0.70%
Geode Capital Management, LLC$1.13M1.10%
Renaissance Technologies LLC$947.3K0.93%
Susquehanna International Group, LLP$897.6K0.52%
Charles Schwab Investment Management Inc$719.6K0.41%

Activity

Mar 31, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
ExitCommon stock$-1.92M-4.6M
-100.00%
0
low
Q1 2026
as of
Balyasny Asset Management L.P.
13F manager
NewCommon stock$1.31M+5.3M
5,288,097
1.28% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
TrimCommon stock$-1.13M-4.6M
-54.49%
3,836,665
0.93% of shares
low
Q2 2026
as of
State Street Corporation
13F manager
ExitCommon stock$-569.3K-1.4M
-100.00%
0
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
AddCommon stock$373.9K+1.5M
+31.84%
6,270,441
1.51% of shares
low
Q2 2023
as of
Barclays PLC
13F manager
TrimCommon stock$-278.2K-214K
-56.46%
165,019
0.04% of shares
low
Q1 2023
as of
Barclays PLC
13F manager
TrimCommon stock$-210.2K-119K
-23.96%
379,016
0.09% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon stock$174.1K+705K
+18.23%
4,570,862
1.10% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Armistice Capital, LLCPassive13G—40,400,067—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SGMO——800677106—